These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 27053679)
1. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Zhang R Open Biol; 2016 Apr; 6(4):150272. PubMed ID: 27053679 [TBL] [Abstract][Full Text] [Related]
2. A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase. Fu Z; Abou-Samra AB; Zhang R Sci Rep; 2015 Dec; 5():18502. PubMed ID: 26687026 [TBL] [Abstract][Full Text] [Related]
3. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues. Zhang R; Zhang K Prog Lipid Res; 2022 Jan; 85():101140. PubMed ID: 34793860 [TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism. Wen Y; Chen YQ; Konrad RJ Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908 [TBL] [Abstract][Full Text] [Related]
5. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4. Landfors F; Chorell E; Kersten S J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100 [TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids. Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Zhen EY; Regmi A; Roell WC; Guo H; Luo MJ; Gimeno RE; Van't Hooft F; Konrad RJ J Lipid Res; 2020 Aug; 61(8):1203-1220. PubMed ID: 32487544 [TBL] [Abstract][Full Text] [Related]
7. A unified model for regulating lipoprotein lipase activity. Zhang R; Zhang K Trends Endocrinol Metab; 2024 Jun; 35(6):490-504. PubMed ID: 38521668 [TBL] [Abstract][Full Text] [Related]
8. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715 [TBL] [Abstract][Full Text] [Related]
9. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355 [TBL] [Abstract][Full Text] [Related]
11. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity. Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789 [TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-like proteins and postprandial partitioning of fatty acids. DiDonna NM; Chen YQ; Konrad RJ Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669 [TBL] [Abstract][Full Text] [Related]
14. Postprandial exercise regulates tissue-specific triglyceride uptake through angiopoietin-like proteins. Liu X; Zhang Y; Han B; Li L; Li Y; Ma Y; Kang S; Li Q; Kong L; Huang K; Song BL; Liu Y; Wang Y JCI Insight; 2024 Aug; 9(16):. PubMed ID: 39171527 [TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4. Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171 [TBL] [Abstract][Full Text] [Related]
16. Regulation of triglyceride metabolism by Angiopoietin-like proteins. Mattijssen F; Kersten S Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269 [TBL] [Abstract][Full Text] [Related]
17. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640 [TBL] [Abstract][Full Text] [Related]
18. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition. Chen YQ; Pottanat TG; Zhen EY; Siegel RW; Ehsani M; Qian YW; Konrad RJ J Lipid Res; 2021; 62():100068. PubMed ID: 33762177 [TBL] [Abstract][Full Text] [Related]
19. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. Balasubramaniam D; Schroeder O; Russell AM; Fitchett JR; Austin AK; Beyer TP; Chen YQ; Day JW; Ehsani M; Heng AR; Zhen EY; Davies J; Glaesner W; Jones BE; Siegel RW; Qian YW; Konrad RJ J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397 [TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8. Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ J Lipid Res; 2021; 62():100112. PubMed ID: 34461133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]